Non-infected Diabetic Foot Ulcer

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

BioStem Technologies
BioStem TechnologiesPOMPANO BEACH, FL
1 program
BR-AMN/A1 trial
Active Trials
NCT06565156Active Not Recruiting72Est. Jun 2026

Trial Timeline

Clinical trial activity over time

2024
2025
2026
BioStem TechnologiesBR-AM

Clinical Trials (1)

Total enrollment: 72 patients across 1 trials

NCT06565156BioStem TechnologiesBR-AM

Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM

Start: Oct 2024Est. completion: Jun 202672 patients
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space